FDA 483 - Valens Molecules Private Limited - September 13, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Valens Molecules Private Limited Unit - II, an API manufacturer in Hyderabad, India, was cited for significant deficiencies in its laboratory controls. The inspection revealed a failure to perform required assay testing for drug substances and issues with the preparation and quality control of microbiological media. These findings indicate a lack of scientifically sound test procedures, posing potential risks to the identity, strength, quality, and purity of their drug substances.
ID · 92298f92-f07d-42a4-88ef-65562273fca9